-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Buntanetap Tartrate in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Buntanetap Tartrate in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Buntanetap Tartrate in Parkinson's Disease Drug Details:Buntanetap (ANVS-401 (Posiphen)) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Buntanetap Tartrate in Frontotemporal Dementia (FTD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Buntanetap Tartrate in Frontotemporal Dementia (FTD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Buntanetap Tartrate in Frontotemporal Dementia (FTD)Drug Details:Buntanetap (ANVS-401 (Posiphen)) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EUC-001 in Traumatic Brain Injury
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EUC-001 in Traumatic Brain Injury report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EUC-001 in Traumatic Brain Injury Drug Details: EU-C-001 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EUC-001 in Intracranial Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EUC-001 in Intracranial Hypertension report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EUC-001 in Intracranial Hypertension Drug Details: EU-C-001 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ST-266 in Trigeminal Neuralgia (Tic Douloureux)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ST-266 in Trigeminal Neuralgia (Tic Douloureux) Drug Details: ST-266 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ST-266 in Optic Neuritis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ST-266 in Optic Neuritis Drug Details: ST-266 is under development for the treatment of ocular...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ST-266 in Glaucoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ST-266 in Glaucoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.ST-266 in Glaucoma Drug Details:ST-266 is under development for the treatment of ocular hypertension,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ST-266 in Ocular Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ST-266 in Ocular Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.ST-266 in Ocular Hypertension Drug Details:ST-266 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – YH-002 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - YH-002 in Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.YH-002 in Colorectal Cancer Drug Details:YH-002 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HMPL-306 in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HMPL-306 in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.HMPL-306 in Acute Myelocytic Leukemia (AML, Acute Myeloblastic...